Future Journal of Pharmaceutical Sciences

Table 5 Percentage recovery results of DOR, LAM and TDF

From: A new stability indicating RP-UPLC method for simultaneous estimation of Doravirine, Lamivudine and Tenofovir disoproxil fumarate in bulk and their combined pharmaceutical formulation

DRUG	Level of addition	Amount added	Drug found (µg/mL)	Average % recovery	%RSD
DRUG	(%)	(µg/mL)	Mean ± SD	Mean ± SD
DOR	50	25	24.93 ± 0.222	99.74 ± 0.601	0.603
	100	50	49.81 ± 0.289
	150	75	74.91 ± 0.385
LAM	50	75	74.103 ± 0.791	99.01 ± 0.745	0.752
	100	150	149.167 ± 0.077
	150	225	222.264 ± 1.864
TDF	50	75	75.39 ± 0.638	100.05 ± 0.892	0.891
	100	150	149.52 ± 1.468
	150	225	224.96 ± 2.162

DOR Doravirine, LAM Lamivudine, TDF Tenofovir disoproxil fumarate, SD standard deviation, %RSD relative standard deviation, RT retention time, µg/mL microgram per millilitre

Back to article page